When is a rash more than just a rash? And what should you be looking for before a patient even tells you something has changed? In our latest episode, cancer nurse practitioners Justin Hargreaves and Gillian Blanchard take a practical look at managing toxicities associated with antibody-drug conjugates, with a particular focus on PADCEV in urothelial cancer. From skin reactions and peripheral neuropathy to glucose changes and ocular symptoms, this episode explores what nurses need to be actively looking for, the questions we should be asking and why early recognition and escalation can make such a difference to patient safety and treatment continuity. This episode has been developed with support from Astellas and is available exclusively to CNSA members. This is a member only episde. To hear the full conversation, visit www.cnsa.org.au/podcast and log in using your CNSA membership details.